Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sitagliptin (januvia) (1 trial)
docetaxel (taxotere) (1 trial)
sunitinib (sutent) (1 trial)
Metabolic Syndrome (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Prostatic Neoplasms (Phase 3)
Syndrome (Phase 3)
Trials (3 total)
Trial APIs (3 total)